• Info
  • Insider Ownership

Insider Trading & Ownership of Keith Regnante

Location
Cambridge, MA
Summary
The estimated net worth of Keith Regnante is at least $641,917 dollars as of 20 Feb 2026. Keith Regnante is the CHIEF FINANCIAL OFFICER of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $641.9K.
Signature
/s/ Keith Regnante
All Insider Reports
All Insider Reports

Notify me when Keith Regnante files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Keith Regnante

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KROS Keros Therapeutics, Inc. Chief Financial Officer $641,917 -$77,483 -11% 18 Feb 2026

Insider Transactions Reported by Keith Regnante:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.